W. Digel

2.1k total citations
29 papers, 1.6k citations indexed

About

W. Digel is a scholar working on Immunology, Genetics and Oncology. According to data from OpenAlex, W. Digel has authored 29 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 11 papers in Genetics and 8 papers in Oncology. Recurrent topics in W. Digel's work include Chronic Lymphocytic Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (6 papers) and Lung Cancer Treatments and Mutations (6 papers). W. Digel is often cited by papers focused on Chronic Lymphocytic Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (6 papers) and Lung Cancer Treatments and Mutations (6 papers). W. Digel collaborates with scholars based in Germany, United States and Switzerland. W. Digel's co-authors include Holger Kirchner, Franz Porzsolt, Helmut Jacobsen, Sibylle Mittnacht, Jürgen Mestan, Heinz Hillen, Dietmar Blohm, Michael Lübbert, H. Heimpel and Norbert Frickhofen and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

W. Digel

28 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Digel Germany 16 596 493 357 312 282 29 1.6k
Jean‐Christophe Noël Belgium 30 421 0.7× 585 1.2× 478 1.3× 527 1.7× 529 1.9× 136 3.0k
Nancy Wehner United States 22 464 0.8× 224 0.5× 780 2.2× 428 1.4× 207 0.7× 37 2.0k
Lap-Ping Chung United Kingdom 21 585 1.0× 297 0.6× 218 0.6× 423 1.4× 82 0.3× 27 1.4k
Yong Sung Choi United States 35 1.6k 2.7× 462 0.9× 240 0.7× 974 3.1× 307 1.1× 116 3.4k
Véronique Pancré France 21 616 1.0× 253 0.5× 171 0.5× 412 1.3× 150 0.5× 49 1.5k
Katherine Siminovitch Canada 26 1.0k 1.7× 331 0.7× 156 0.4× 917 2.9× 514 1.8× 49 3.5k
Erik Svedmyr Sweden 25 1.0k 1.7× 769 1.6× 117 0.3× 181 0.6× 370 1.3× 53 1.9k
Junichi Yata Japan 25 1.0k 1.7× 219 0.4× 94 0.3× 368 1.2× 171 0.6× 105 1.9k
Huifang Lu United States 17 864 1.4× 418 0.8× 198 0.6× 310 1.0× 168 0.6× 58 2.0k
Narsing A. Rao United States 33 596 1.0× 184 0.4× 222 0.6× 553 1.8× 572 2.0× 127 3.6k

Countries citing papers authored by W. Digel

Since Specialization
Citations

This map shows the geographic impact of W. Digel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Digel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Digel more than expected).

Fields of papers citing papers by W. Digel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Digel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Digel. The network helps show where W. Digel may publish in the future.

Co-authorship network of co-authors of W. Digel

This figure shows the co-authorship network connecting the top 25 collaborators of W. Digel. A scholar is included among the top collaborators of W. Digel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Digel. W. Digel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paz‐Ares, Luis, Helen J. Ross, Mary O’Brien, et al.. (2008). Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer. British Journal of Cancer. 98(10). 1608–1613. 125 indexed citations
2.
Schneider, Claus-Peter, David F. Heigener, S Gütz, et al.. (2008). Epidermal Growth Factor Receptor-Related Tumor Markers and Clinical Outcomes with Erlotinib in Non-small Cell Lung Cancer: An Analysis of Patients from German Centers in the TRUST Study. Journal of Thoracic Oncology. 3(12). 1446–1453. 88 indexed citations
3.
Stoelben, Erich, W. Digel, Michael Henke, & Bernward Passlick. (2006). Multimodale Therapie des nichtkleinzelligen Bronchialkarzinoms. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 131(2). 110–114.
4.
Digel, W. & Michael Lübbert. (2005). DNA methylation disturbances as novel therapeutic target in lung cancer: Preclinical and clinical results. Critical Reviews in Oncology/Hematology. 55(1). 1–11. 57 indexed citations
5.
Brink, Ingo, Michael Mix, Svenja Rühland, et al.. (2004). Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. 31(12). 1614–1620. 155 indexed citations
6.
Hoelzer, Dieter, Nicola Gökbuget, W. Digel, et al.. (2002). Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia. Blood. 99(12). 4379–4385. 125 indexed citations
7.
Schumacher, Tilmann, Ingo Brink, Michael Mix, et al.. (2001). FDG-PET imaging for the staging and follow-up of small cell lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. 28(4). 483–488. 95 indexed citations
8.
Kulmburg, Peter, Marc R. Radke, & W. Digel. (1998). Lymphotoxin-α is an autocrine growth factor for chronic lymphocytic leukemia B cells. Leukemia. 12(4). 493–498. 10 indexed citations
9.
Digel, W., Franz Porzsolt, Mathias Schmid, et al.. (1992). High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and type B chronic lymphocytic leukemia.. Journal of Clinical Investigation. 89(5). 1690–1693. 87 indexed citations
10.
Prümmer, Otto, Norbert Frickhofen, W. Digel, H. Heimpel, & Franz Porzsolt. (1991). Spontaneous interferon-α antibodies in a patient with pure red cell aplasia and recurrent cutaneous carcinomas. Annals of Hematology. 62(2-3). 76–80. 16 indexed citations
11.
Digel, W., et al.. (1991). Pharmacokinetics and biological activity in subcutaneous long-term administration of recombinant interferon-γ in cancer patients. Cancer Immunology Immunotherapy. 34(3). 169–174. 5 indexed citations
12.
Digel, W., M. Schmid, Gerhard Heil, et al.. (1991). Human interleukin-7 induces proliferation of neoplastic cells from chronic lymphocytic leukemia and acute leukemias. Blood. 78(3). 753–759. 70 indexed citations
13.
Frickhofen, Norbert, et al.. (1990). Antilymphocyte immunoglobulins stimulate peripheral blood lymphocytes to proliferate and release lymphokines. European Journal Of Haematology. 44(4). 244–251. 33 indexed citations
14.
Späth‐Schwalbe, E., et al.. (1989). Elevated plasma cortisol levels during interferon-γ treatment. Immunopharmacology. 17(3). 141–145. 27 indexed citations
15.
Digel, W., Martin Štefanič, C. Buck, et al.. (1989). Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia. Blood. 73(5). 1242–1246. 15 indexed citations
16.
Porzsolt, Franz, W. Digel, Helmut Jacobsen, et al.. (1988). Different antitumor mechanisms of interferon-alpha in the treatment of hairy cell leukemia and renal cell cancer. Cancer. 61(2). 288–293. 6 indexed citations
17.
Raghavachar, Aruna, Norbert Frickhofen, W. Digel, Franz Porzsolt, & H. Heimpel. (1988). Lymphokines as inhibitors of hematopoietic cell proliferation.. PubMed. 14(2-3). 471–84. 9 indexed citations
18.
Porzsolt, Franz, A Raghavachar, W. Digel, Claus R. Bartram, & H. Heimpel. (1987). Strategy for the treatment of hairy cell leukemia.. PubMed. 1(4). 334–7. 6 indexed citations
19.
Digel, W., Fabrizio Marcucci, & Holger Kirchner. (1983). SHORT COMMUNICATIONS: Induction of Interferon Gamma in Leucocyte Cultures of the Peripheral Blood of Mice. Journal of Interferon Research. 3(1). 65–69. 3 indexed citations
20.
Kirchner, Holger, et al.. (1982). Interferons and bacterial infections. Journal of Molecular Medicine. 60(14). 740–742. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Christophe Noël Breakdown of academic impact, for papers by Nancy Wehner Breakdown of academic impact, for papers by Lap-Ping Chung Breakdown of academic impact, for papers by Yong Sung Choi Breakdown of academic impact, for papers by Véronique Pancré Breakdown of academic impact, for papers by Katherine Siminovitch Breakdown of academic impact, for papers by Erik Svedmyr Breakdown of academic impact, for papers by Junichi Yata Breakdown of academic impact, for papers by Huifang Lu Breakdown of academic impact, for papers by Narsing A. Rao
Rankless by CCL
2026